MAFLD: what 2 years of the redefinition of fatty liver disease has taught us
Metabolic dysfunction–associated fatty liver disease (MAFLD) has appeared as the leading liver disease worldwide. Whereas the terminology nonalcoholic fatty liver disease (NAFLD) mainly reflected a negative selection and exclusion of alcohol-related liver disease (ALD), the new definition made its f...
Main Authors: | Felix Grabherr, Christoph Grander, Maria Effenberger, Julian Schwärzler, Herbert Tilg |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-11-01
|
Series: | Therapeutic Advances in Endocrinology and Metabolism |
Online Access: | https://doi.org/10.1177/20420188221139101 |
Similar Items
-
Using Infodemiology Metrics to Assess Public Interest in Liver Transplantation: Google Trends Analysis
by: Maria Effenberger, et al.
Published: (2021-08-01) -
WHAT HAS MRI TAUGHT US ABOUT DIAGNOSIS AND OUTCOME IN OSTEOARTHRITIS?
by: Arden, N
Published: (2011) -
Oxygen therapy – What managing COVID 19 has taught us!
by: Kiran Vishnu Narayan
Published: (2022-01-01) -
Lessons from COVID 19 - What the Virus has Taught Us
by: Obiyathulla Ismath Bacha
Published: (2021-03-01) -
What Has Neuroimaging Taught Us on the Neurobiology of Yoga? A Review
by: June van Aalst, et al.
Published: (2020-07-01)